Table 4.
Complications, surgical interventions, and visual outcomes in our cohort of paediatric anterior uveitis.
| Number of patients | JIA N = 64 |
Undifferentiated N = 33 |
Other N = 37 |
Total N = 134 |
|---|---|---|---|---|
| Complications | 26 (19.4%) | 14 (10.4%) | 15 (11.2%) | 55 (41%) |
| Band keratopathy | 16 (12%) | 6 (4.5%) | 6 (4.5%) | 28 (21%) |
| Posterior synechiae | 12 (9%) | 7 (5%) | 7 (5%) | 26 (20%) |
| Cataracts | 14 (10.4%) | 3 (2%) | 8 (6%) | 25 (19%) |
| Secondary glaucoma | 8 (6%) | 3 (2%) | 9 (7%) | 20 (15%) |
| Ocular hypertension | 9 (7%) | 3 (2%) | 1 (0.7%) | 13 (10%) |
| Deprivational amblyopia | 7 (5%) | 1 (0.7%) | 5 (4%) | 13 (10%) |
| Macular oedema | 2 (1.5%) | 0 | 1 (0.7%) | 4 (3%) |
| Optic disc swelling | 0 | 2 (1.5%) | 1 (0.7%) | 3 (2.2%) |
| Surgical interventions | 21 (16%) | 3 (2%) | 18 (13%) | 22 (16%) |
| Cataract surgery | 10 (7.5%) | 2 (1.5%) | 4 (3%) | 16 (12%) |
| Glaucoma surgeries | 7 (5.2%) | 2 (1.5%) | 3 (2%) | 12 (9%) |
| - Trabeculotomy | 1 (0.7%) | 1 (0.7%) | 1 (0.7%) | 3 (2.2%) |
| - Goniotomy | 1 (0.7%) | 0 | 0 | 1 (0.7%) |
| - Iridectomy | 1 (0.7%) | 1 (0.7%) | 0 | 2 (1.5%) |
| - Baerveldt Implant | 2 (1.5%) | 0 | 1 (0.7%) | 3 (2.2%) |
| - Ahmed Valve Implant | 2 (1.5%) | 0 | 1 (0.7%) | 3 (2.2%) |
| EDTA chelation | 3 (2.2%) | 0 | 1 (0.7%) | 4 (3%) |
| YAG Capsulotomy | 1 (0.7%) | 1 (0.7%) | 2 (1.5%) | 4 (3%) |
| Vitrectomy | 1 (0.7%) | 0 | 0 | 1 (0.7%) |
| Visual outcomes | ||||
| BCVA ≥ 20/40 | 46 (34%) | 29 (22%) | 38 (28%) | 113 (84%) |
| <20/40–20/100 | 5 (4%) | 3 (2%) | 3 (2%) | 11 (8%) |
| BCVA < 20/100 | 6 (4.5%) | 1 (1%) | 3 (2%) | 10 (7.5%) |
JIA juvenile idiopathic arthritis, EDTA ethylenediamine tetra acetic acid, YAG yttrium-aluminium-garnet, BCVA best corrected visual acuity.